{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T20:39:52Z","timestamp":1774039192885,"version":"3.50.1"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T00:00:00Z","timestamp":1676851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018571","name":"Specific Research Project of Guangxi for Research Bases and Talents","doi-asserted-by":"publisher","award":["GK AD21220042"],"award-info":[{"award-number":["GK AD21220042"]}],"id":[{"id":"10.13039\/501100018571","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82160589"],"award-info":[{"award-number":["No. 82160589"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The associations between metabolic dysfunction-associated fatty liver disease (MAFLD) and cancer development, especially extrahepatic cancers, are unknown. The aims of the current study were to investigate the cancer incidence rates of MAFLD and analyze the associations between MAFLD and the development of cancers.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This historical cohort study included participants who underwent ultrasonographic detection of hepatic steatosis at a tertiary hospital in China from January 2013 to October 2021. MAFLD was diagnosed in accordance with <jats:italic>The International Expert Consensus Statement.<\/jats:italic> Cox proportional hazards regression modeling was used to assess the associations between MAFLD and the development of cancers.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of the 47,801 participants, 16,093 (33.7%) had MAFLD. During the total follow-up of 175,137 person-years (median 3.3 years), the cancer incidence rate in the MAFLD group was higher than that in the non-MAFLD group [473.5 <jats:italic>vs<\/jats:italic>. 255.1 per 100,000 person-years; incidence rate ratio 1.86; 95% confidence interval (CI) 1.57\u20132.19]. After adjustment for age, gender, smoking status, and alcohol status, MAFLD was moderately associated with cancers of the female reproductive system\/organs (labium, uterus, cervix, and ovary) [hazard ratio (HR) 2.24; 95% CI 1.09\u20134.60], thyroid (HR 3.64; 95% CI 1.82\u20137.30), and bladder (HR 4.19; 95% CI 1.15\u201315.27) in the total study cohort.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>MAFLD was associated with the development of cancers of the female reproductive system\/organs (labium, uterus, cervix, and ovary), thyroid, and bladder in the total study cohort.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2023.985858","type":"journal-article","created":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T15:27:05Z","timestamp":1676906825000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["The relationship between metabolic dysfunction-associated fatty liver disease and the incidence rate of extrahepatic cancer"],"prefix":"10.3389","volume":"14","author":[{"given":"Suosu","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanrong","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofeng","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junzhang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujie","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongjun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingguang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianrong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30702","article-title":"Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018: A systematic review and meta-analysis","volume":"70","author":"Zhou","year":"2019","journal-title":"Hepatology."},{"key":"B3","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, united kingdom, and united states for the period 2016-2030","volume":"69","author":"Estes","year":"2018","journal-title":"J Hepatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.67","article-title":"NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study","volume":"104","author":"Adams","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1038\/s41598-022-06205-8","article-title":"Relationship between the dynamics of non-alcoholic fatty liver disease and incident diabetes mellitus","volume":"12","author":"Han","year":"2022","journal-title":"Sci Rep"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154893","article-title":"Investigators as. the presence of NAFLD influences the transition of metabolically healthy to metabolically unhealthy obesity and the ten-year cardiovascular disease risk: A population-based cohort study","volume":"128","author":"Kouvari","year":"2022","journal-title":"Metabolism."},{"key":"B7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12876-020-01278-z","article-title":"Association between NAFLD and risk of prevalent chronic kidney disease: why there is a difference between east and west","volume":"20","author":"Zhang","year":"2020","journal-title":"BMC Gastroenterol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-324191","article-title":"Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies","volume":"71","author":"Mantovani","year":"2021","journal-title":"Gut"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.08.018","article-title":"The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity - a longitudinal cohort study","volume":"71","author":"Allen","year":"2019","journal-title":"J Hepatol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31845","article-title":"Cancer risk in patients with biopsy-confirmed nonalcoholic fatty liver disease: A population-based cohort study","volume":"74","author":"Simon","year":"2021","journal-title":"Hepatology."},{"key":"B11","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.cgh.2020.05.009","article-title":"Associations between nonalcoholic fatty liver disease and cancers in a Large cohort in China","volume":"19","author":"Wang","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.12.033","article-title":"The health impact of MAFLD, a novel disease cluster of NAFLD, is amplified by the integrated effect of fatty liver disease-related genetic variants","volume":"20","author":"Liu","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154955","article-title":"Metabolic dysfunction-associated fatty liver disease and the risk of 24 specific cancers","volume":"127","author":"Liu","year":"2022","journal-title":"Metabolism."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2007.05002.x","article-title":"Asia-Pacific working party on n. guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-pacific region: executive summary","volume":"22","author":"Farrell","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2217\/14622416.6.6.639","article-title":"UK Biobank: from concept to reality","volume":"6","author":"Ollier","year":"2005","journal-title":"Pharmacogenomics."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PloS Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2022.03.016","article-title":"Metabolic associated fatty liver disease (MAFLD) increases the risk of systemic complications and mortality. a meta-analysis and systematic review of 12,620,736 individuals","volume":"28","author":"Quek","year":"2022","journal-title":"Endocr Pract"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31420","article-title":"From NAFLD to MAFLD: Implications of a premature change in terminology","volume":"73","author":"Younossi","year":"2021","journal-title":"Hepatology."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.01.015","article-title":"The sub-Saharan Africa position statement on the redefinition of fatty liver disease: From NAFLD to MAFLD","volume":"74","author":"Spearman","year":"2021","journal-title":"J Hepatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2021.11.038","article-title":"An observational data meta-analysis on the differences in prevalence and risk factors between MAFLD vs NAFLD","volume":"74","author":"Lim","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.12.035","article-title":"Change from NAFLD to MAFLD increases the awareness of fatty liver disease in primary care physicians and specialists","volume":"74","author":"Fouad","year":"2021","journal-title":"J Hepatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/srep44877","article-title":"Hypertension and breast cancer risk: a systematic review and meta-analysis","volume":"7","author":"Han","year":"2017","journal-title":"Sci Rep"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1042\/CS20200307","article-title":"Unravelling the tangled web of hypertension and cancer","volume":"135","author":"Sionakidis","year":"2021","journal-title":"Clin Sci (Lond)."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-321661","article-title":"Metabolic syndrome, metabolic comorbid conditions and risk of early-onset colorectal cancer","volume":"70","author":"Chen","year":"2021","journal-title":"Gut."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.2337\/db20-0084","article-title":"Is type 2 diabetes causally associated with cancer risk? evidence from a two-sample mendelian randomization study","volume":"69","author":"Yuan","year":"2020","journal-title":"Diabetes."},{"key":"B27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12916-020-01848-8","article-title":"Associations of six adiposity-related markers with incidence and mortality from 24 cancers-findings from the UK biobank prospective cohort study","volume":"19","author":"Parra-Soto","year":"2021","journal-title":"BMC Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g7607","article-title":"Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies","volume":"350","author":"Tsilidis","year":"2015","journal-title":". BMJ"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.09.001","article-title":"Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study","volume":"51","author":"Dasarathy","year":"2009","journal-title":"J Hepatol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v25.i11.1307","article-title":"Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice","volume":"25","author":"Zhou","year":"2019","journal-title":"World J Gastroenterol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.985858\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T15:27:09Z","timestamp":1676906829000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.985858\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,20]]},"references-count":30,"alternative-id":["10.3389\/fendo.2023.985858"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.985858","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,20]]},"article-number":"985858"}}